The AMYPAD team is participating in the 14th Human Amyloid Imaging conference (HAI). This event is organised from January 15-17, 2020, in Miami, Florida. The program includes presentations on human imaging of amyloid-beta and other biomarkers that pertain to Alzheimer’s-related disease.

If you have an opportunity to attend as well, we would love to meet you. Please feel free to check out our posters at the poster session. Alternatively, if you would like to book an appointment with one of our member, please contact at info@amypad.org.

Meet our team

January 15^th:

• Poster #5, “Early detection of amyloid load using 18F-Florbetaben (FBB) PET”, Santiago Bullich (LMI)
• Poster #17, “[11C]PiB Amyloid quantification and Choice of Reference Region”, Fiona Heeman (VUmc)
• Poster #38, “Amyloid PET variability due to variation in MRI protocol and anatomical segmentation”, Richard Manber (IXICO)

January 16^th:

• Poster #74, “Quantitative regional amyloid burden and white matter alterations in preclinical Alzheimer’s disease”, Lyduine Collij (VUmc)
• Poster #84, “Preliminary Quantitative Results of the AMYPAD Prognostic and Natural History Study”, Gemma Salvadó (BBRC)

January 17^th: Join the AMYPAD oral presentation at 2:30-2:45pm:

• “Reducing sample sizes to detect amyloid accumulation”, Isadora Lopes Alves (VUmc)

Follow us on Twitter: @IMI_AMYPAD

Interested to receive the latest AMYPAD news? Click here to subscribe!